These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 25442458)

  • 1. Excellent outcomes for transcatheter aortic valve replacement within 1 year of opening a low-volume centre and consideration of requirements.
    Chevalier F; Poulin F; Lamarche Y; Viet Le VH; Gallant M; Daoust A; Heylbroeck C; Serri K; Beaulieu Y; Demers P; El-Hamamsy I; Jeanmart H; Pagé P; Schampaert E; Palisaitis D; Généreux P
    Can J Cardiol; 2014 Dec; 30(12):1576-82. PubMed ID: 25442458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience.
    Amrane H; Porta F; van Boven AJ; Boonstra PW; Hofma SH; Head SJ; Kappetein AP
    Interact Cardiovasc Thorac Surg; 2014 Nov; 19(5):777-81. PubMed ID: 25074233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and clinical pathways to optimize length of stay after transcatheter aortic valve replacement.
    Lauck SB; Wood DA; Achtem L; Baumbusch J; Boone RH; Cheung A; Dvir D; Stub D; Tan JS; Ye J; Webb JG
    Can J Cardiol; 2014 Dec; 30(12):1583-7. PubMed ID: 25475463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility.
    Omer S; Kar B; Cornwell LD; Blaustein A; Levine GN; Ali N; Jneid H; Paniagua D; Atluri PV; Bechara CF; Kougias P; Ruma M; Preventza O; Bozkurt B; Carabello BA; Bakaeen FG
    JAMA Surg; 2013 Dec; 148(12):1087-93. PubMed ID: 24048246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balloon-expandable prostheses for transcatheter aortic valve replacement.
    Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
    Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of an interdisciplinary heart team-based transcatheter aortic valve implantation programme: short and mid-term outcomes.
    Martínez GJ; Seco M; Jaijee SK; Adams MR; Cartwright BL; Forrest P; Celermajer DS; Vallely MP; Wilson MK; Ng MK
    Intern Med J; 2014 Sep; 44(9):876-83. PubMed ID: 24965193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
    Wood DA; Lauck SB; Cairns JA; Humphries KH; Cook R; Welsh R; Leipsic J; Genereux P; Moss R; Jue J; Blanke P; Cheung A; Ye J; Dvir D; Umedaly H; Klein R; Rondi K; Poulter R; Stub D; Barbanti M; Fahmy P; Htun N; Murdoch D; Prakash R; Barker M; Nickel K; Thakkar J; Sathananthan J; Tyrell B; Al-Qoofi F; Velianou JL; Natarajan MK; Wijeysundera HC; Radhakrishnan S; Horlick E; Osten M; Buller C; Peterson M; Asgar A; Palisaitis D; Masson JB; Kodali S; Nazif T; Thourani V; Babaliaros VC; Cohen DJ; Park JE; Leon MB; Webb JG
    JACC Cardiovasc Interv; 2019 Mar; 12(5):459-469. PubMed ID: 30846085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement.
    Saia F; Latib A; Ciuca C; Gasparetto V; Napodano M; Sticchi A; Anderlucci L; Marrozzini C; Naganuma T; Alfieri O; Facchin M; Hoxha B; Moretti C; Marzocchi A; Colombo A; Tarantini G
    Am Heart J; 2014 Nov; 168(5):798-806. PubMed ID: 25440810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
    Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
    Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with on-label and off-label use of the transcatheter heart valve in the United States.
    Lardizabal JA; Macon CJ; O'Neill BP; Singh V; Martinez CA; Alfonso C; Cohen MG; Williams DB; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):124-8. PubMed ID: 24659187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.